Yucai Wang
University of Science and Technology Liaoning(CN)University of Science and Technology of China(CN)Toyota Motor Corporation (Switzerland)(CH)Mayo Clinic(US)Rochester Institute of Technology(US)Eli Lilly (United States)(US)Anhui Medical University(CN)WinnMed(US)The Ohio State University Wexner Medical Center(US)Hematology\Oncology Clinic(US)Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital(CN)Mayo Clinic in Arizona(US)Ningxia Water Conservancy(CN)National Science Centre(PL)Mayo Clinic in Florida(US)Southern Medical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials(2019)815 cited
- → Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years(2017)438 cited
- → Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma(2016)172 cited
- → Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium(2023)160 cited
- → Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis(2020)131 cited
- → Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center(2019)128 cited